样式: 排序: IF: - GO 导出 标记为已读
-
For more events and to book online, please visit www.rsm.ac.uk/events J. Roy. Soc. Med. (IF 17.3) Pub Date : 2024-03-13
-
Medicine: the pursuit of understanding J. Roy. Soc. Med. (IF 17.3) Pub Date : 2024-03-13 Kamran Abbasi
-
-
-
-
-
Heresy, witchcraft, Jean Gerson, scepticism and the use of placebo controls. J. Roy. Soc. Med. (IF 17.3) Pub Date : 2023-11-22 R Kirakosian,L Möllenbrink,G Zamore,T J Kaptchuk,K Jensen
-
Paul Owren, Christopher Bjerkelund and the dawn of controlled trials in Norway. J. Roy. Soc. Med. (IF 17.3) Pub Date : 2023-11-22 Magne Nylenna
-
The differences and overlaps between 'explanatory' and 'pragmatic' controlled trials: a historical perspective. J. Roy. Soc. Med. (IF 17.3) Pub Date : 2023-11-22 Paul Glasziou,Robert Matthews,Isabelle Boutron,Iain Chalmers,Peter Armitage
-
A deathly silence: why has the number of people found decomposed in England and Wales been rising? J. Roy. Soc. Med. (IF 17.3) Pub Date : 2023-11-21 Lucinda Hiam,Theodore Estrin-Serlui,Danny Dorling,Martin McKee,Jon Minton
OBJECTIVES The number of deaths occurring in private homes in England and Wales had been rising for years, increasingly rapidly from 2020. Media stories and research linked decomposing bodies found in private homes with pandemic-related social isolation. We aim to explore whether these incidents are one-offs or part of a wider trend. DESIGN Descriptive analysis of publicly available Office for National
-
The difference in all-cause mortality between COVID-19 patients treated with standard of care plus placebo and those treated with standard of care alone: a network meta-analysis of randomised controlled trials of immunomodulatory kinase inhibitors. J. Roy. Soc. Med. (IF 17.3) Pub Date : 2023-11-16 Ping-Tao Tseng,Bing-Syuan Zeng,Chih-Wei Hsu,Trevor Thompson,Brendon Stubbs,Po-Ren Hsueh,Kuan-Pin Su,Yen-Wen Chen,Tien-Yu Chen,Yi-Cheng Wu,Pao-Yen Lin,Andre F Carvalho,Dian-Jeng Li,Ta-Chuan Yeh,Cheuk-Kwan Sun,Yu-Shian Cheng,Yow-Ling Shiue,Chih-Sung Liang,Yu-Kang Tu
OBJECTIVES The aim of this network meta-analysis (NMA) was to assess whether participants assigned to a placebo and standard of care (SoC) group had different major coronavirus disease 2019 (COVID-19)-related outcomes than those assigned to SoC alone. DESIGN Frequentist model-based NMA. SETTING We searched for randomised controlled trials (RCTs) of Janus kinase/Bruton tyrosine kinase inhibitors for
-
Adverse events after first and second doses of COVID-19 vaccination in England: a national vaccine surveillance platform self-controlled case series study. J. Roy. Soc. Med. (IF 17.3) Pub Date : 2023-11-03 Ruby Sm Tsang,Utkarsh Agrawal,Mark Joy,Rachel Byford,Chris Robertson,Sneha N Anand,William Hinton,Nikhil Mayor,Debasish Kar,John Williams,William Victor,Ashley Akbari,Declan T Bradley,Siobhan Murphy,Dermot O'Reilly,Rhiannon K Owen,Antony Chuter,Jillian Beggs,Gary Howsam,Aziz Sheikh,F D Richard Hobbs,Simon de Lusignan
OBJECTIVES To estimate the incidence of adverse events of interest (AEIs) after receiving their first and second doses of coronavirus disease 2019 (COVID-19) vaccinations, and to report the safety profile differences between the different COVID-19 vaccines. DESIGN We used a self-controlled case series design to estimate the relative incidence (RI) of AEIs reported to the Oxford-Royal College of General
-
Drift and doom: from workforce to the climate crisis. J. Roy. Soc. Med. (IF 17.3) Pub Date : 2023-11-01 Kamran Abbasi
-
Prevalence of multiple long-term conditions (multimorbidity) in England: a whole population study of over 60 million people. J. Roy. Soc. Med. (IF 17.3) Pub Date : 2023-10-31 Jonathan Valabhji,Emma Barron,Adrian Pratt,Nasrin Hafezparast,Rupert Dunbar-Rees,Ellie Bragan Turner,Kate Roberts,Jacqueline Mathews,Robbie Deegan,Victoria Cornelius,Jason Pickles,Gary Wainman,Chirag Bakhai,Desmond G Johnston,Edward W Gregg,Kamlesh Khunti
OBJECTIVES To determine the prevalence of multiple long-term conditions (MLTC) at whole English population level, stratifying by age, sex, socioeconomic status and ethnicity. DESIGN A whole population study. SETTING Individuals registered with a general practice in England and alive on 31 March 2020. PARTICIPANTS 60,004,883 individuals. MAIN OUTCOME MEASURES MLTC prevalence, defined as two or more
-
Beyond government accountability: the role of medical schools in addressing the NHS workforce crisis. J. Roy. Soc. Med. (IF 17.3) Pub Date : 2023-10-31 Tomas Ferreira
-
Rigour and science in drug regulatory approval. J. Roy. Soc. Med. (IF 17.3) Pub Date : 2023-10-01 Kamran Abbasi
-
Trial analysis by treatment allocated or by treatment received? Origins of 'the intention-to-treat principle' to reduce allocation bias: Part 1. J. Roy. Soc. Med. (IF 17.3) Pub Date : 2023-10-01 I Chalmers,R Matthews,P Glasziou,I Boutron,P Armitage
-
The Women's Soccer World Cup Final 2023: gender equity and alcohol promotion. J. Roy. Soc. Med. (IF 17.3) Pub Date : 2023-09-28 Frank Houghton,Daisy Houghton
-
From Elvis to Sinead O'Connor: 50 years of drugs, rock and roll and premature death. J. Roy. Soc. Med. (IF 17.3) Pub Date : 2023-09-22 John Ashton,Mark A Bellis
-
Racial, ethnic and regional differences in the effect of sodium-glucose co-transporter 2 inhibitors and glucagon-like peptide 1 receptor agonists on cardiovascular and renal outcomes: a systematic review and meta-analysis of cardiovascular outcome trials. J. Roy. Soc. Med. (IF 17.3) Pub Date : 2023-09-21 Setor K Kunutsor,Kamlesh Khunti,Samuel Seidu
OBJECTIVES The cardiorenal protective effects of sodium-glucose co-transporter 2 inhibitors (SGLT2-Is) and glucagon-like peptide 1 receptor agonists (GLP1-RAs) across racial and ethnic groups are not well defined. By conducting a systematic review and meta-analysis of all randomised, placebo-controlled, cardiovascular disease (CVD) outcomes trials (CVOTs), we aimed to compare racial/ethnic as well
-
The NHS Long Term Workforce Plan: an ambitious leap or a misstep? J. Roy. Soc. Med. (IF 17.3) Pub Date : 2023-09-12 Tomas Ferreira,Alexander M Collins
-
The value of supporting women's rights. J. Roy. Soc. Med. (IF 17.3) Pub Date : 2023-09-01 Kamran Abasi
-
The Innovative Medicines Fund: a universal model for faster and fairer access to new promising medicines or a Trojan horse for low-value creep? J. Roy. Soc. Med. (IF 17.3) Pub Date : 2023-08-24 Aris Angelis,Ajay Aggarwal,Alec Miners,Richard Grieve,John Cairns,Andrew Briggs
-
An assault upon women: reproductive rights in the US in the shadow of the 2022 US Supreme Court Ruling (the Dobbs ruling). J. Roy. Soc. Med. (IF 17.3) Pub Date : 2023-08-18 Margo Hill,Frank Houghton,Mary Ann Keogh Hoss
-
Health, wellbeing, and equity: the tenets of health professionalism. J. Roy. Soc. Med. (IF 17.3) Pub Date : 2023-08-01 Kamran Abbasi
-
Addressing ethnic and global health inequalities in the era of artificial intelligence healthcare models: a call for responsible implementation. J. Roy. Soc. Med. (IF 17.3) Pub Date : 2023-07-19 Mohammad R Ali,Claire A Lawson,Angela M Wood,Kamlesh Khunti
-
On joining the club that nobody wishes to belong to. J. Roy. Soc. Med. (IF 17.3) Pub Date : 2023-07-18 John Ashton,Maggi Morris
-
The effects of community interventions on unplanned healthcare use in patients with multimorbidity: a systematic review. J. Roy. Soc. Med. (IF 17.3) Pub Date : 2023-07-14 Tavleen Wasan,Benedict Hayhoe,Meryem Cicek,Elena Lammila-Escalera,Dasha Nicholls,Azeem Majeed,Geva Greenfield
OBJECTIVES To summarise the impact of community-based interventions for multimorbid patients on unplanned healthcare use. The prevalence of multimorbidity (co-existence of multiple chronic conditions) is rapidly increasing and affects one-third of the global population. Patients with multimorbidity have complex healthcare needs and greater unplanned healthcare usage. Community-based interventions allow
-
Impact of SARS-CoV-2 infective exacerbation of chronic obstructive pulmonary disease on clinical outcomes in a prospective cohort study of hospitalised adults. J. Roy. Soc. Med. (IF 17.3) Pub Date : 2023-07-05 Catherine Hyams,George Qian,George Nava,Robert Challen,Elizabeth Begier,Jo Southern,Maria Lahuerta,Jennifer L Nguyen,Jade King,Anna Morley,Madeleine Clout,Nick Maskell,Luis Jodar,Jennifer Oliver,Gillian Ellsbury,John M McLaughlin,Bradford D Gessner,Adam Finn,Leon Danon,James W Dodd,
OBJECTIVES To determine whether acute exacerbations of chronic obstructive pulmonary disease (AECOPD) triggered by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), have worse outcomes than AECOPD caused by other infectious agents or non-infective AECOPD (NI-COPD). DESIGN A two-hospital prospective cohort study of adults hospitalised with acute respiratory disease. We compared outcomes
-
Unheard voices in medicine that must be heard. J. Roy. Soc. Med. (IF 17.3) Pub Date : 2023-07-01 Kamran Abbasi
-
The (Harry) Gold standard: angina, suggestion and the path to the 'double-blind' test and clinical pharmacology. Part 3: the double blind and the rise of 'clinical pharmacology'. J. Roy. Soc. Med. (IF 17.3) Pub Date : 2023-06-30 Scott H Podolsky
-
The (Harry) Gold standard: angina, suggestion and the path to the 'double blind' test and clinical pharmacology. Part 2: the path to the 'double blind'. J. Roy. Soc. Med. (IF 17.3) Pub Date : 2023-06-28 Scott H Podolsky
-
Psychology of envy towards medical colleagues. J. Roy. Soc. Med. (IF 17.3) Pub Date : 2023-06-28 Donald A Redelmeier,Edward E Etchells,Umberin Najeeb
-
COVID-19 risk mitigation in reopening mass cultural events: population-based observational study for the UK Events Research Programme in Liverpool City Region. J. Roy. Soc. Med. (IF 17.3) Pub Date : 2023-06-23 Girvan Burnside,Christopher P Cheyne,Gary Leeming,Michael Humann,Alistair Darby,Mark A Green,Alexander Crozier,Simon Maskell,Kay O'Halloran,Elena Musi,Elinor Carmi,Naila Khan,Debra Fisher,Rhiannon Corcoran,Jake Dunning,W John Edmunds,Kukatharmini Tharmaratnam,David M Hughes,Liora Malki-Epshtein,Malcolm Cook,Ben M Roberts,Eileen Gallagher,Kate Howell,Meera Chand,Robin Kemp,Matthew Boulter,Tom Fowler
OBJECTIVES To understand severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission risks, perceived risks and the feasibility of risk mitigations from experimental mass cultural events before coronavirus disease 2019 (COVID-19) restrictions were lifted. DESIGN Prospective, population-wide observational study. SETTING Four events (two nightclubs, an outdoor music festival and a business
-
Trends in SARS-CoV-2 infection and vaccination in school staff, students and their household members from 2020 to 2022 in Wales, UK: an electronic cohort study. J. Roy. Soc. Med. (IF 17.3) Pub Date : 2023-06-22 Emily Lowthian,Hoda Abbasizanjani,Stuart Bedston,Ashley Akbari,Laura Cowley,Richard Fry,Rhiannon K Owen,Joe Hollinghurst,Igor Rudan,Jillian Beggs,Emily Marchant,Fatemeh Torabi,Simon de Lusignan,Tom Crick,Graham Moore,Aziz Sheikh,Ronan A Lyons
OBJECTIVES We investigated SARS-CoV-2 infection trends, risk of SARS-CoV-2 infection and COVID-19 vaccination uptake among school staff, students and their household members in Wales, UK. DESIGN Seven-day average of SARS-CoV-2 infections and polymerase chain reaction tests per 1000 people daily, cumulative incidence of COVID-19 vaccination uptake and multi-level Poisson models with time-varying covariates
-
Registration of essential medicines in Kenya, Tanzania and Uganda: a retrospective analysis. J. Roy. Soc. Med. (IF 17.3) Pub Date : 2023-06-21 A Green,R Lyus,M Ocan,A M Pollock,P Brhlikova
OBJECTIVES To audit national drug registers (NDRs) in Kenya, United Republic of Tanzania and Uganda with respect to national Essential Medicine Lists (EMLs) and to conduct an analysis of highly registered products including a sub-analysis of highly registered antimicrobial products. DESIGN Retrospective analysis of registration of essential medicines and medicinal products on NDRs as of February 2018
-
GPT-4: the future of artificial intelligence in medical school assessments. J. Roy. Soc. Med. (IF 17.3) Pub Date : 2023-06-15 Lois Haruna-Cooper,Mohammed Ahmed Rashid
-
Should we be so radical as to overlook facts? J. Roy. Soc. Med. (IF 17.3) Pub Date : 2023-06-09 Martin Blay,Miguel Duarte,Patrick Charbon,Emmanuel Poulet,Martin Debbané,Sébastien Weibel,Nader Perroud,Mario Speranza
-
Policies on doctors' declaration of interests in medical organisations: a thematic analysis. J. Roy. Soc. Med. (IF 17.3) Pub Date : 2023-06-08 Victoria Tzortziou Brown,Margaret McCartney,Patrycja Talaga,Richard Huxtable,Andrew Papanikitas,Elizabeth David-Barrett
OBJECTIVES There has been growing concern about doctors' conflicts of interests (COIs) but it is unclear what processes and tools exist to enable the consistent declaration and management of such interests. This study mapped existing policies across a variety of organisations and settings to better understand the degree of variation and identify opportunities for improvement. DESIGN Thematic analysis
-
Is an independent NHS an impossible dream? J. Roy. Soc. Med. (IF 17.3) Pub Date : 2023-06-01 Kamran Abbasi
-
Facilitating genetic testing after death: the ongoing duty of care to the deceased and their relatives. J. Roy. Soc. Med. (IF 17.3) Pub Date : 2023-06-01 Catherine Dennis,Fleur S Van Dijk,Anneke Lucassen
-
Financial difficulty in the medical profession. J. Roy. Soc. Med. (IF 17.3) Pub Date : 2023-05-22 Asta Medisauskaite,Rowena Viney,Antonia Rich,Kirsty Alexander,Milou Silkens,Laura Knight,David Harrison,Paul Crampton,Ann Griffin
-
Large language models will not replace healthcare professionals: curbing popular fears and hype. J. Roy. Soc. Med. (IF 17.3) Pub Date : 2023-05-18 Arun James Thirunavukarasu
-
Patient safety in prisons: a multi-method analysis of reported incidents in England. J. Roy. Soc. Med. (IF 17.3) Pub Date : 2023-05-17 Isobel J McFadzean,Kate Davies,Thomas Purchase,Adrian Edwards,Stuart Hellard,Darren M Ashcroft,Anthony J Avery,Sandra Flynn,Tom Hewson,Melanie Jordan,Richard Keers,Maria Panagioti,Verity Wainwright,Florian Walter,Jenny Shaw,Andrew Carson-Stevens
OBJECTIVES Prisoners use healthcare services three times more frequently than the general population with poorer health outcomes. Their distinct healthcare needs often pose challenges to safe healthcare provision. This study aimed to characterise patient safety incidents reported in prisons to guide practice improvement and identify health policy priorities.Design: We carried out an exploratory multi-method
-
Socioeconomic inequalities of Long COVID: a retrospective population-based cohort study in the United Kingdom J. Roy. Soc. Med. (IF 17.3) Pub Date : 2023-05-10 Sharmin Shabnam, Cameron Razieh, Hajira Dambha-Miller, Tom Yates, Clare Gillies, Yogini V Chudasama, Manish Pareek, Amitava Banerjee, Ichiro Kawachi, Ben Lacey, Eva JA Morris, Martin White, Francesco Zaccardi, Kamlesh Khunti, Nazrul Islam
ObjectivesTo estimate the risk of Long COVID by socioeconomic deprivation and to further examine the inequality by sex and occupation.DesignWe conducted a retrospective population-based cohort stud...
-
Human, all too human - why artificial intelligence cannot "author" papers. J. Roy. Soc. Med. (IF 17.3) Pub Date : 2023-05-01 Kamran Abbasi
-
The globalisation of the chemical industry and the public health scandal of Forever Chemicals. J. Roy. Soc. Med. (IF 17.3) Pub Date : 2023-04-26 John Ashton
-
The carbon footprint of products used in five common surgical operations: identifying contributing products and processes J. Roy. Soc. Med. (IF 17.3) Pub Date : 2023-04-13 Chantelle Rizan, Robert Lillywhite, Malcom Reed, Mahmood F Bhutta
ObjectivesMitigating carbon footprint of products used in resource-intensive areas such as surgical operating rooms will be important in achieving net zero carbon healthcare. The aim of this study ...
-
Borderline personality disorder: a spurious condition unsupported by science that should be abandoned. J. Roy. Soc. Med. (IF 17.3) Pub Date : 2023-04-12 Roger Mulder,Peter Tyrer
-
Why better interpretation of science leads to better care. J. Roy. Soc. Med. (IF 17.3) Pub Date : 2023-04-01 Kamran Abbasi
-
Falling down the global ranks: life expectancy in the UK, 1952-2021. J. Roy. Soc. Med. (IF 17.3) Pub Date : 2023-03-15 Lucinda Hiam,Danny Dorling,Martin McKee
-
Public health and the addiction industry: preying on human weakness. J. Roy. Soc. Med. (IF 17.3) Pub Date : 2023-03-10 John Ashton
-
Robotic techniques benefit anaesthesia too. J. Roy. Soc. Med. (IF 17.3) Pub Date : 2023-03-09 Sean P Hughes,Iain Macintyre
-
UK's life expectancy rankings slide signals a system failure. J. Roy. Soc. Med. (IF 17.3) Pub Date : 2023-03-01 Kamran Abbasi
-
Impact of COVID-19 vaccination on COVID-19 hospital admissions in England during 2021: an observational study J. Roy. Soc. Med. (IF 17.3) Pub Date : 2023-02-24 Felicity Cornforth, Lucie Webber, Gabriele Kerr, Hywell Dinsdale, Azeem Majeed, Peter Greengross
ObjectivesTo examine the impact of COVID-19 vaccination on hospital admissions in England in 2021.DesignObservational study of emergency admissions for COVID-19 by vaccination status in people 16 y...
-
Intensive versus standard blood pressure control in older persons with or without diabetes: a systematic review and meta-analysis of randomised controlled trials J. Roy. Soc. Med. (IF 17.3) Pub Date : 2023-02-24 Samuel Seidu, Harini Willis, Setor K Kunutsor, Kamlesh Khunti
ObjectivesTo assess and compare the benefits and harms of intensive versus standard blood pressure (BP) control in older people with or without diabetes mellitus (DM).DesignSystematic review and me...
-
GPs finally challenge authority of Royal College of Surgeons. J. Roy. Soc. Med. (IF 17.3) Pub Date : 2023-02-27 Nick Black
-
Multi-organ impairment and long COVID: a 1-year prospective, longitudinal cohort study J. Roy. Soc. Med. (IF 17.3) Pub Date : 2023-02-14 Andrea Dennis, Daniel J Cuthbertson, Dan Wootton, Michael Crooks, Mark Gabbay, Nicole Eichert, Sofia Mouchti, Michele Pansini, Adriana Roca-Fernandez, Helena Thomaides-Brears, Matt Kelly, Matthew Robson, Lyth Hishmeh, Emily Attree, Melissa Heightman, Rajarshi Banerjee, Amitava Banerjee
ObjectivesTo determine the prevalence of organ impairment in long COVID patients at 6 and 12 months after initial symptoms and to explore links to clinical presentation.DesignProspective cohort stu...
-
Reducing the pressures of outpatient care: the potential role of patient-reported outcomes J. Roy. Soc. Med. (IF 17.3) Pub Date : 2023-02-09 Olalekan Lee Aiyegbusi, Sarah E Hughes, John Devin Peipert, Liv Marit Valen Schougaard, Roger Wilson, Melanie J Calvert
The global demand for hospital treatment exceeds capacity.The COVID-19 pandemic has exacerbated this issue, leading to increased backlogs and longer wait times for patients. The amount of outpatien...
-
Fixing the NHS with public health and public engagement. J. Roy. Soc. Med. (IF 17.3) Pub Date : 2023-02-01 Kamran Abbasi